Episode Details
Back to Episodes
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
Published 2 months, 3 weeks ago
Description
FDA approves three new therapies spanning autoimmune disease, HIV, and cardiovascular risk, DualityBio and Teva strike major biopharma deals, and Israel Ortiz makes the case for preventive maintenance in manufacturing.